@article{f3479b17b42d42d2a61eb92b73dcb74a,
title = "Synergy between Cetuximab and Chemotherapy in Tumors of the Gastrointestinal Tract",
author = "Reshma Mahtani",
note = "Cetuximab is a recently approved monoclonal antibody that targets the epidermal growth factor receptor, a receptor tyrosine kinase involved in the development and progression of colorectal cancer (CRC) and other solid tumors. Cetuximab, as a single agent or in combination with chemotherapy, has demo ...",
year = "2008",
language = "American English",
volume = "13",
journal = "The Oncologist",
}